Active Ingredient Omalizumab
Active Ingredient Details
What is Omalizumab?
An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.
What is the usage for Omalizumab?
Omalizumab is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma that is due to year-round allergens. Controlling symptoms of asthma helps you maintain your normal activities and cuts down on time lost from work or school. Omalizumab is also used to treat hives from an unknown cause (chronic idiopathic urticaria-CIU). This medication must be used regularly to be effective. It does not work right away. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, salbutamol) as prescribed.
How many products in the NDC database contain Omalizumab?
The NDC database has 4 products with the active ingredient Omalizumab. The following table lists all the products that have this active ingredient.
NDC Products with Omalizumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 50242-040 | Proprietary Name: Xolair | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
| 50242-214 | Proprietary Name: Xolair Pfs | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
| 50242-215 | Proprietary Name: Xolair Pfs | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
| 50242-227 | Proprietary Name: Xolair | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE |